Abstract
Retinal diseases is one of the leading causes of blindness and impairment in Russia (25% of all cases of visual impairment). The most common retinal diseases that cause impairment are age-related macular degeneration (AMD) and diabetic macular edema (DME) with diabetic retinopathy. According to the Russian clinical guidelines, the first-line therapy for AMD and DME surgical treatment is intravenous injection. This study aims to estimate the availability of anti-VEGF treatment for patients with AMD and DME and demand for intravitreal injections (IVI) in the Russian Federation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
